
==== Front
J Curr Ophthalmol
J Curr Ophthalmol
JCO
J Curr Ophthalmol
Journal of Current Ophthalmology
2452-2325
Wolters Kluwer - Medknow India

JCO-35-416
10.4103/joco.joco_25_24
Erratum
Erratum: Intracameral Injection of Methotrexate for Treatment of Epithelial Ingrowth
Oct-Dec 2023
10 8 2024
10 8 2024
35 4 416416
Copyright: © 2024 Journal of Current Ophthalmology
2024
https://creativecommons.org/licenses/by-nc-sa/4.0/ This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Intracameral Injection of Methotrexate for Treatment of Epithelial Ingrowth
==== Body
pmcIn the article titled “Intracameral Injection of Methotrexate for Treatment of Epithelial Ingrowth” published in pages 115-117, Issue 1, Volume 34 in the Journal of Current Ophthalmology, the authors acknowledge a dosage error in the article.1 They have requested a correction, stating that in the original publication, the dose for intracameral injection of methotrexate was incorrectly listed as 400 mg/0.1 ml. The accurate dosage for intracameral injection of methotrexate for treating epithelial ingrowth throughout the entire manuscript is 400 μg/0.1 ml.
==== Refs
REFERENCE

1 Salari F Fakhraie G Asadi Amoli F Zarei-Ghanavati M Intracameral injection of methotrexate for treatment of epithelial ingrowth J Curr Ophthalmol 2022 34 115 7 35620380
